Trial Profile

Lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: the German STAR/STELLA cohort

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lopinavir/ritonavir (Primary) ; Antiretrovirals
Indications HIV infections
Focus Therapeutic Use
Acronyms STAR/STELLA

Most Recent Events

16 Sep 2015 New trial record
06 Nov 2014 Interim results in 1409 patients after 144 weeks' treatment presented at the 12th International Congress on Drug Therapy in HIV Infection.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com